Entering text into the input field will update the search result below

Allergan holds off Novartis' generic version of Combigan

Jul. 20, 2018 12:29 PM ETAllergan plc (AGN) StockNVS, AGNBy: Douglas W. House, SA News Editor4 Comments
  • Allergan (AGN -0.7%) prevails in its patent infringement litigation with Novartis' (NVS +1.8%) Sandoz unit related to glaucoma med COMBIGAN (brimonidine tartrate/timolol maleate ophthalmic solution).
  • A New Jersey judge ruled that Sandoz's marketing application seeking approval for a generic version infringes on a composition of matter patent that expires in 2022.
  • Allergan lost an earlier case with Sandoz related to three other COMBIGAN patents.
  • Source: Bloomberg

Recommended For You

Related Stocks

SymbolLast Price% Chg
AGN--
Allergan plc